MedicineNews

Oklahoma Judge Lessens J&J Opioid Fines to $465 Million

An Oklahoma judge Friday stated Johnson & Johnson should pay that state $465 million for kindling the opioid epidemic through the deceptive advertising and marketing of painkillers, down from his original award of $572 million.

The decision by Cleveland County District Judge Thad Balkman in Norman, Oklahoma, got here in the first case to go to trial out of 2,700 nationally by states, counties, and cities in quest of to carry drug firms responsible for the lethal outbreak.

Balkman lowered the amount he had awarded in August by $107 million after agreeing with New Brunswick, New Jersey stationed J&J that he had made a math fallacy.

J&J said it’d appeal, and that the award and finding of liability had been “neither backed by the facts nor the regulation.”

A spokesperson for Oklahoma Attorney General Mike Hunter mentioned that the office is reviewing the choice and will formally reply within the next few days.

Opioids were concerned in almost 400,000 overdose deaths from 1999 to 2017, according to the U.S. CDCP

Following a non-jury trial, Balkman ruled in August that Oklahoma had proven that J&J engaged in misleading advertising and marketing about the advantages of painkillers and that their addictive risks triggered a public nuisance in the type of the opioid crisis.

Hunter had sought to have J&J pay $17 billion to help fund addiction remedy and other services to fix damage from the opioid epidemic over the next 3 three decades.

Balkman, however, awarded only sufficient money for one year of programs, saying Oklahoma did not help its claims concerning the need to decrease the epidemic in future years.

Tags
Show More

Joseph Flowers

Joseph is leading the team writing under the medicine category. Before joining health dialysis, he has worked with many research organization and also in labs and hence his understandings on the field of medicine is vast and exciting. His articles hold the account for every recalled medication and even those medicines whose approval has risen a storm in the market. Personality wise he is a very soft-spoken person.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close